Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2005-08-29
2009-08-25
Aeder, Sean E (Department: 1642)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S007100
Reexamination Certificate
active
07579152
ABSTRACT:
The present invention relates to compositions and methods for the use of SENP1 as a marker for cancer diagnosis, specifically prostate cancer. Still further, it relates to the use of inhibitors of SENP1 to inhibit cell proliferation of a neoplasm or tumor cell and to treat a hyperproliferative disease.
REFERENCES:
Tockman et al (Cancer Res., 1992, 52:2711s-2718s).
Alberts et al. (Molecular Biology of the Cell, 3rd edition, 1994, p. 465).
Lewin, B. (Genes VI, Oxford University Press, Inc., NY, Chapter 29, 1997).
Greenbaum et al. (Genome Biology, 2003, vol. 4, Issue 9, pp. 117.1-117.8).
Mallampalli et al. (Biochem. J. vol. 318, 1996, pp. 333-341).
Fu et al (EMBO Journal, 1996, vol. 15, pp. 4392-4401).
Bachant et al., “The SUMO-1 Isopeptidase Smt4 Is Linked to Centromeric Cohesion through SUMO-1 Modification of DNA Topoisomerase II,”Molecular Cell, 9: 1169-1182, 2002.
Best et al., “SUMO-1 protease-1 regulates gene transcription through PML,”Mol. Cell, 10: 843-855, 2002.
Chauchereau et al., “Sumoylation of the progesterone receptor and of the steroid receptor coactivator SRC-1,”J. Biol. Chem., 278(14): 12335-43, 2003.
Colombo et al., “The adenovirus protein Gam1 interferes with sumoylation of histone deacetylase 1,”EMBO Rep., 3: 1062-1068, 2002.
Culig, “Androgen receptors in prostate cancer,”J. Urol., 170: 1363-1369, 2003.
David et al., “SUMO-1 modification of histone deacetylase 1 (HDAC1) modulates its biological activities,”J. Biol. Chem., 277(26): 23658-63, 2002.
De Marzo et al., “Pathological and molecular aspects of prostate cancer,”Lancet, 361: 955-964, 2003.
De Ruijter et al., “Histone deacetylases (HDACs): characterization of the classical HDAC family,”Biochem. J., 370: 737-749, 2003.
Debes et al., “The role of androgens and the androgen receptor in prostate cancer,”Cancer Letters, 187: 1-7, 2002.
Desterro et al., “SUMO-1 Modification of IκBα Inhibits NF-κB Activation,”Molecular Cell, 2: 233-239, 1998.
Duprez et al., “SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation,”Journal of Cell Science, 112: 381-393, 1999.
Freiman et al., “Regulating the Regulators: Lysine Modifications Make Their Mark,”Cell, 112: 11-17, 2003.
Fu et al., “Androgen Receptor Acetylation GovernstransActivation and MEKK1-Induced Apoptosis without Affecting In Vitro Sumoylation andtrans-Repression Function,”Mol. Cell. Biol., 22(10): 3373-3388, 2002.
Gaughan et al., “Tip60 and Histone Deacetylase 1 Regulate Androgen Receptor Activity through Changes to the Acetylation Status of the Receptor,”J. Biol. Chem., 277(29): 25904-25913, 2002.
Gelmann, “Molecular Biology of the Androgen Receptor,”J. Clin. Oncol., 20(13): 3001-3015, 2002.
Gill, “Post-translational modifiation by the small ubiquitin-related modifier SUMO has big effects on transcription factor activity,”Curr. Opin. Genet. Dev., 13: 108-113, 2003.
Girdwood et al., “p300 Transcriptional Repression Is Mediated by SUMO Modification,”Molecular Cell, 11: 1043-1054, 2003.
Glass et al., “The coregulator exchange in transcriptional functions of nuclear receptors,”Genes&Development, 14: 121-141, 2000.
Gong et al., “Differential regulation of sentrinized proteins by a novel sentrin-specific protease,”J. Biol. Chem., 275: 3355-3359, 2000.
Gong et al., “Molecular cloning and characterization of human AOS1 and UBA2, components of the sentrin-activating enzyme complex,”FEBS Letters, 448: 185-189, 1999.
Gong et al., “Preferential Interaction of Sentrin with a Ubiquitin-conjugating Enzyme, Ubc9,”J. Biol. Chem., 272(45): 28198-28201, 1997.
Gostissa et al., “Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1,”The EMBO Journal, 18(22): 6462-6471, 1999.
Grossmann et al., “Androgen Receptor Signaling in Androgen-Refractory Prostate Cancer,”Journal of the National Cancer Institute, 93(22): 1687-1697, 2001.
Hang et al., “Association of the human SUMO-1 protease SENP2 with the nuclear pore,”J. Biol. Chem., 277: 19961-19966, 2002.
Hay, “Protein modification by SUMO,”TRENDS in Biochemical Sciences, 26(5): 332-333, 2001.
Heinlein et al., “Androgen Receptor (AR) Coregulators: An Overview,”Endocrine Reviews, 23(2): 175-200, 2002.
Hochstrasser, “SP-RING for SUMO: New Functions Bloom for a Uniquitin-like Protein,”Cell, 107: 5-8, 2001.
Johnson et al., “An E3-like Factor that Promotes SUMO Conjugation to the Yeast Septins,”Cell, 106: 735-744, 2001.
Kagey et al., “The Polycomb Protein Pc2 Is a SUMO E3,”Cell, 113: 127-137, 2003.
Kahyo et al., “Involvement of PIAS1 in the Sumoylation of Tumor Suppressor p53,”Molecular Cell, 8: 713-718, 2001.
Kamitani et al., “Identification of Three Major Sentrinization Sites in PML,”J. Biol. Chem., 273(41): 26675-26682, 1998.
Kamitani et al., “Preferential Modification of Nuclear Proteins by a Novel Ubiquitin-like Molecule,”J. Biol. Chem., 272(22): 14001-14004, 1997.
Kim et al., “A new SUMO-1-specific protease, SUSP1, that is highly expressed in reproductive organs,”J. Biol. Chem., 275: 14102-14106, 2000.
Kirsh et al., “The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase,”EBMO J., 21: 2682-2691, 2002.
Kotaja et al., “The nuclear receptor interaction domain of GRIP1 is modulated by covalent attachment of SUMO-1,”J. Biol. Chem., 277: 30283-30288, 2002.
Le Drean et al., “Potentiation of Glucocorticoid Receptor Transcriptional Activity by Sumoylation,”Endocrinology, 143(9): 3482-3489, 2002.
Lee et al., “Recent advances in androgen receptor action,”Cell. Mol. Life Sci., 60: 1613-1622, 2003.
Li et al., “A new protease required for cell-cycle progression in yeast,”Nature, 398: 246-251, 1999.
Li et al., “Heterogeneous Expression and Functions of Androgen Receptor Co-Factors in Primary Prostate Cancer,”American Journal of Pathology, 161(4): 1467-1474, 2002.
Li et al., “The yeast ULP2 (SMT4) gene encodes a novel protease specific for the ubiquitin-like Smt3 protein,”Mol. Cell. Biol., 20: 2367-2377, 2000.
Lin et al., “Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase,”EMBO J., 21: 4037-4048, 2002.
Mahajan et al., “A Small Upbiquitin-Related Polypeptide Involved in Targeting RanGAP1 to Nuclear Pore Complex Protein RanBP2,”Cell, 88: 97-107, 1997.
McKenna et al., “Combinatorial control of gene expression by nuclear receptors and coregulators,”Cell, 108: 465-474, 2002.
Melchior, “SUMO—Nonclassical Ubiquitin,”Annu. Rev. Cell Dev. Biol., 16: 591-626, 2000.
Muller et al., “c-Jun and p53 Activity Is Modulated by SUMO-1 Modification,”J. Biol. Chem., 275(18): 13321-13329, 2000.
Muller et al., “Sumo, Ubiquitin's Mysterious Cousin,”Nature Reviews, 2: 202-210, 2001.
Nagy et al., “Nuclear Receptor Repression Mediated by a Complex Containing SMRT, mSin3A, and Histone Deacetylase,”Cell, 89: 373-380, 1997.
Nawaz et al., “Proteasome-dependent degradation of the human estrogen receptor,”Proc. Natl. Acad. Sci. USA, 96: 1858-1862, 1999.
Nishida et al., “A novel mammalian Smt3-specific isopeptidase 1 (SMT3IP1) localized in the nucleolus at interphase,”Eur. J. Biochem., 267: 6423-6427, 2000.
Nishida et al., “Characterization of a novel mammalian SUMO-1/Smt3-specific isopeptidase, a homologue of rat axam, which is an axin-binding protein promoting beta-catenin degradation,”J. Biol. Chem., 276: 39060-39066, 2001.
Nishida et al., “PIAS1 and PIASxα Function as SUMO-E3 Ligases toward Androgen Receptor and Re
Aeder Sean E
Board of Regents the University of Texas System
Fulbright & Jaworski LLP
LandOfFree
SENP1 as a marker of cancer development and target for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with SENP1 as a marker of cancer development and target for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and SENP1 as a marker of cancer development and target for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4131131